Skip to main content
SpringerLink
Log in

Synopsis of the Most Important Biopharmaceutical Facts About Nifedipine/Adalat

  • Conference paper
Adalat

  • 69 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BPI (ed) (1990) Rote Liste. Cantor, Aulendorf, FRG

    Google Scholar 

  2. Dyrszka H, Wahn B (1977) Klinisches Bild und Therapie einer Überdosis des Koronartherapeutikums Nifedipin (Adalat®). Inn Med 4(l):31–34

    Google Scholar 

  3. Schiffl H, Ziupa J, Schollmeyer P (1984) Clinical features and management of nifedipine overdosage in a patient with renal insufficiency. Clin Tox 22(4):387–395

    Article  CAS  Google Scholar 

  4. Hemngton DM, Insley BM, Weinmann GG (1986) Nifedipine overdose. Am J Med 81:344–346

    Article  Google Scholar 

  5. Wells TG, Graham CJ, Moss MM, Kearns GL (1990) Nifedipine poisoning in a child. Pediatrics 86(l):91–94

    PubMed  CAS  Google Scholar 

  6. Whitebloom D, Fitzharris J (1988) Nifedipine overdose. Clin Cardiol 11:505–506

    Article  PubMed  CAS  Google Scholar 

  7. Strubelt O (1989) Vergiftungen durch Verapamil und andere Calciumantagonisten. DMW 114:1623–1627

    Article  CAS  Google Scholar 

  8. Hruby K (1984) Nebenwirkungen und Intoxikationen durch Kalziumantagonisten. Wiener Med Wochenschr 82:22–23

    Google Scholar 

  9. Strubelt O, Diederich K-W (1986) Experimental investigations on the antidotal treatment of nifedipine ovedosage. Clin Toxicol 24(2):135–149

    Article  CAS  Google Scholar 

  10. Streifler J, Wittenberg C, Rosenfeld JB (1983) Effects of different single doses of nifedipine on blood pressure, renal function, plasma aldosterone and renin in hypertensive subjects. In: Kaltenbach M, Neufeld HN (eds) Fifth International Adalat Symposium. Excerpta Medica, Amsterdam, pp. 164–171

    Google Scholar 

  11. Higuchi S, Shiobara Y (1978) Quantitative determination of nifedipine in human plasma by selected monitoring. Biomed Mass Spectrom 5(3):220–223

    Article  PubMed  CAS  Google Scholar 

  12. Rämsch K-D (Bayer AG) (1981) Zur Pharmakokinetik von Nifedipin. Schwerpunkt Med 4(4):55–61

    Google Scholar 

  13. Foster TS, Hamann SR, Richards VR, Bryant PJ, Graves DA, McAllister RG (1983) Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol 23:161–170

    PubMed  CAS  Google Scholar 

  14. Kleinbloesem CH, van Brummelen P, van de Linde JA, Voogd PJ, Breimer DD (1984) Nifedipine: Kinetics and dynamics in healthy subjects. Clin Pharmacol Ther 35(6):742–749

    Article  PubMed  CAS  Google Scholar 

  15. Horster FA, Duhm B, Maul W, Medenwald H, Patzschke K, Wegner LA (Bayer AG) (1972) Klinische Untersuchungen zur Pharmakokinetik von radioaktiv markiertem 4-(2′-Nitro-phenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimetylester. Arzneimittelforschung (Drug Res.) 22(2):330–334

    CAS  Google Scholar 

  16. Penny WJ, Lewis MJ (1989) Nifedipine is excreted in human milk. Eur J Clin Pharmacol 36:427–428

    Article  PubMed  CAS  Google Scholar 

  17. Rosenkranz H, Schlossmann J, Scholtan W. (1974) Die Bindung von 4-(2′-Nitrophenyl)-2,6-chmethyl-l,4-dihydropyridin-3,5-dicarbonsäuredimethylester (Nifedipine) sowie von anderen koronarwirksamen Stoffen an die Eiweißkörper des Serums. Arzneimittelforschung (Drug Res) 24(4):455–466

    CAS  Google Scholar 

  18. Kleinbloesem CH (1985) Nifedipine: clinical pharmacokinetics and haemodynamic effects. Pasmans, The Hague, The Netherlands, pp. 9–31

    Google Scholar 

  19. Guengerich FP, Peterson LA, Böcker RH (1988) Cytochrome P-450-catalyzed hydroxylation and carboxylic acid ester cleavage of hantzsch pyridine esters. J Biol Chem 263(17): 8176–8183

    PubMed  CAS  Google Scholar 

  20. Spital A, Scandüng JD (1983) Nifedipine in continuous ambulatory peritoneal dialysis. Arch Intern Med 143:2025

    Article  PubMed  CAS  Google Scholar 

  21. Kleinbloesem CH, van Harten J, Wilson JPH, van Brummelen, Danhof M, Breimer DD Nifedipine: Kinetics and haemodynamic effects in patients with liver cirrhosis after i. v. and oral administration. In: Kleinbloesem CH (ed) Nifedipine, clinical pharmacokinetics and haemodynamic effects. Pasmans, The Hague, The Netherlands, pp. 135–147

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharma Research Center, Bayer AG, W-5600, Wuppertal, Germany

    P.-J. Schattenberg

Authors
  1. P.-J. Schattenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abtl. Innere Medizin/Kardiologie, Medizinische Hochschule Hannover, Karl-Wiechert-Allee 9, D-3000, Hannover 61, Germany

    P. R. Lichtlen

  2. Cardiologia Policlinico, Roma, Italy

    A. Reale

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schattenberg, PJ. (1991). Synopsis of the Most Important Biopharmaceutical Facts About Nifedipine/Adalat. In: Lichtlen, P.R., Reale, A. (eds) Adalat. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85498-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85498-9_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85500-9

  • Online ISBN: 978-3-642-85498-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation